Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/c53277d5-2134-440e-85bc-8a69ec9a9425/

CYP

Cynata Therapeutics Limited
Chart
0.28 AUD
Latest Week 2026-06-05
HealthcareBiotechnologyMICRO
Snapshot 2026-06-07 · 0.0w · Fresh
0.62
OS Score
57.0%
Value
56.0%
Quality
57.0%
Momentum
0/9
F-Score
0.565
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.46
V
Value Analysis
Cheapness relative to fundamentals
57.0%ile
P/B
10.8×
FCF Yield
-0.148
SH Yield
-0.118
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
42.00000000
/100 — 1=cheapest
VC2 (Trending Value)
42.00000000
/100
VC3 (Buyback)
42.00000000
/100
Negative FCF yield (-14.8%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
56.0%ile
ROE
-1.570
ROA
-1.305
Current
4.40
F-Score
0/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
5yr Consist
No
F-Score of 0/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
57.0%ile
6M Return
5.6%
12M Return
67.6%
12-1 Mom
97.1%
Risk-Adj
1.46
Vol 252d
66.3%
Vol 60d
147.0%
↑ Expanding
Max DD 12M
-28.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 97% is very strong — a clear uptrend. Near-term vol (147%) is expanding vs long-term (66%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.62
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 145 peers
Sector Value %ile
62.3%
Sector Quality %ile
61.6%
P/B z-score
0.28
Sector Avg OS
45.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 93.0% 98.0% 91.0%
SDI SDI Limited 95.0% 86.0% 87.0% 94.0%
TRU TruScreen Group Limited 94.0% 82.0% 80.0% 82.0%
TRI TrivarX Limited 94.0% 82.0% 81.0% 82.0%
VBS Vectus Biosystems Limited 92.0% 80.0% 79.0% 80.0%
VFX VISIONFLEX FPO [VFX] 92.0% 81.0% 79.0% 81.0%
AHE Adheris Health Limited 91.0% 79.0% 77.0% 79.0%
ACW Actinogen Medical Limited 91.0% 79.0% 78.0% 79.0%
Factor Interactions
Volatility Expanding
60-day vol (147%) significantly exceeds 252-day (66%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
0.0% avg (3 factors)
Quality
D
33.3% avg (3 factors)
Momentum
A
76.5% avg (4 factors)
Risk
F
6.1% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.620—0—
Value %ile0.570—0—
Quality %ile0.560—0—
Momentum %ile0.570—0—
F-Score0.000—1—
Confidence0.313—1—
Volatility0.663—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
10.77
FCF Yield
-14.8%
Shareholder Yield
Div + net buyback / mktcap
-11.8%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-157.0%
Return on Assets
-130.5%
Current Ratio
4.40
External Financing
Net issuance — lower=better
1.203
MomentumPrice trend strength over different horizons
6M Return
5.6%
12M Return
67.6%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
97.1%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.46
Growth & StabilityEarnings trajectory, consistency, and capital allocation
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
0
Dividend Yield
0.0%
Buyback Yield
-11.8%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
42
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
42
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
42
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity